Patents by Inventor Stelios Tzannis

Stelios Tzannis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apparatus for administering small volume oral transmucosal dosage forms
    Patent number: 10709881
    Abstract: Systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject using a device are disclosed. The dispensing device includes a lock-out feature and a means to retard or prevent saliva and/or moisture ingress such that the drug dosage forms in the device remain dry prior to administration.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: July 14, 2020
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Andrew Poutiatine, Charles Rampersaud, Bruce Edwards, Edmond Chiu, Thomas Schreck, Stelios Tzannis, Lawrence Hamel, William Kolosi, Sascha Retailleau
  • SMALL-VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS
    Publication number: 20200022918
    Abstract: Small-volume oral transmucosal dosage forms or NanoTabs® comprising a predetermined amount of a pharmaceutically active drug are provided. Exemplary applications include use of the NanoTabs® to administer a drug for the treatment of acute, post-operative or breakthrough pain.
    Type: Application
    Filed: January 9, 2019
    Publication date: January 23, 2020
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela PALMER, Thomas SCHRECK, Stelios TZANNIS, Lawrence HAMEL, Andrew I. POUTIATINE
  • Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
    Patent number: 10507180
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: December 17, 2019
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • Small-volume oral transmucosal dosage forms
    Patent number: 10342762
    Abstract: Small-volume oral transmucosal dosage forms or NanoTabs® comprising a predetermined amount of a pharmaceutically active drug are provided. Exemplary applications include use of the NanoTabs® to administer a drug for the treatment of acute, post-operative or breakthrough pain.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: July 9, 2019
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Lawrence Hamel, Andrew I. Poutiatine
  • SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS CONTAINING SUFENTANIL FOR TREATMENT OF PAIN
    Publication number: 20190125659
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Application
    Filed: October 5, 2018
    Publication date: May 2, 2019
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela PALMER, Thomas SCHRECK, Stelios TZANNIS, Larry HAMEL, Andrew I. POUTIATINE
  • Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
    Patent number: 10245228
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Grant
    Filed: July 20, 2017
    Date of Patent: April 2, 2019
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • RAPAMYCIN ANALOGS SHOWING IMPROVED mTORC1 SPECIFICITY
    Publication number: 20180258100
    Abstract: In various embodiments novel rapamycin analogs are provides that show improved mTORC1 specificity.
    Type: Application
    Filed: August 26, 2016
    Publication date: September 13, 2018
    Inventors: Matthew Alan GREGORY, Steven MOSS, Michael VELARDE, Timothy POWERS, Stelios TZANNIS
  • SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS CONTAINING SUFENTANIL FOR TREATMENT OF PAIN
    Publication number: 20180161270
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Application
    Filed: July 20, 2017
    Publication date: June 14, 2018
    Inventors: Pamela PALMER, Thomas SCHRECK, Stelios TZANNIS, Larry HAMEL, Andrew I. POUTIATINE
  • APPARATUS FOR ADMINISTERING SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS
    Publication number: 20170259051
    Abstract: Systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject using a device are disclosed. The dispensing device includes a lock-out feature and a means to retard or prevent saliva and/or moisture ingress such that the drug dosage forms in the device remain dry prior to administration.
    Type: Application
    Filed: May 8, 2017
    Publication date: September 14, 2017
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela PALMER, Andrew POUTIATINE, Charles RAMPERSAUD, Bruce EDWARDS, Edmond CHIU, Thomas SCHRECK, Stelios TZANNIS, Lawrence HAMEL, William KOLOSI, Sascha RETAILLEAU
  • Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
    Patent number: 9744129
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Grant
    Filed: April 6, 2016
    Date of Patent: August 29, 2017
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • Methods and apparatus for administering small volume oral transmucosal dosage forms
    Patent number: 9642996
    Abstract: Systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject using a device are disclosed. The dispensing device includes a lock-out feature and a means to retard or prevent saliva and/or moisture ingress such that the drug dosage forms in the device remain dry prior to administration.
    Type: Grant
    Filed: June 16, 2014
    Date of Patent: May 9, 2017
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Andrew Poutiatine, Charles Rampersaud, Bruce Edwards, Edmond Chiu, Thomas Schreck, Stelios Tzannis, Lawrence Hamel, William Kolosi, Sascha Retailleau
  • SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS CONTAINING SUFENTANIL FOR TREATMENT OF PAIN
    Publication number: 20160213606
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Application
    Filed: April 6, 2016
    Publication date: July 28, 2016
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela PALMER, Thomas SCHRECK, Stelios TZANNIS, Larry HAMEL, Andrew I. POUTIATINE
  • Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
    Patent number: 9320710
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: April 26, 2016
    Assignee: AcelRX Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • Methods for administering small volume oral transmucosal dosage forms using a dispensing device
    Patent number: 9289583
    Abstract: Systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject using a device are disclosed. The dispensing device includes a lock-out feature and a means to retard or prevent saliva and/or moisture ingress such that the drug dosage forms in the device remain dry prior to administration.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: March 22, 2016
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Andrew I Poutiatine, Charles Rampersaud, Bruce Edwards, Edmond Chiu, Thomas Schreck, Stelios Tzannis, Larry Hamel
  • MULTI-COMPONENT FORMULATION FOR IMPROVING NEUROLOGICAL FUNCTION
    Publication number: 20150209306
    Abstract: In certain embodiments multi-component formulations are provided where the formulations comprise a first component comprising one or more vitamins selected from the group consisting of one or more B vitamins, vitamin C, vitamin D, vitamin E, co-enzyme Q10, vitamin K, and folate; a second component comprising one or more elements selected from the group consisting of selenium, lithium, magnesium, and molybdenum; a third component comprising one or more omega-3 fatty acids; and a fourth component comprising one or more amino acids selected from the group consisting of trimethylglycine, N-acetyl cysteine, S-adenosyl methionine, L-tryptophan, and glutathione.
    Type: Application
    Filed: August 7, 2013
    Publication date: July 30, 2015
    Inventors: Dale E. Bredesen, Stelios Tzannis
  • Storage and dispensing devices for administration of oral transmucosal dosage forms
    Patent number: 9066847
    Abstract: Drug storage and dispensing devices for dispensing dosage forms to the oral mucosa of a patient are disclosed. The drug storage and dispensing device is a single dose applicator or a device which includes a means to retard or prevent saliva and/or moisture ingress such that the drug dosage forms in the device remain dry prior to administration.
    Type: Grant
    Filed: July 3, 2007
    Date of Patent: June 30, 2015
    Assignee: AceIRx Pharmaceuticals, Inc.
    Inventors: Andrew I. Poutiatine, Charles Rampersaud, Bruce Edwards, Edmond Chiu, Stelios Tzannis, Pamela Palmer, William Kolosi, Sascha Retailleau
  • SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS CONTAINING SUFENTANIL FOR TREATMENT OF PAIN
    Publication number: 20150105424
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Application
    Filed: October 17, 2014
    Publication date: April 16, 2015
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • Delivery of drugs
    Patent number: 8956602
    Abstract: Formulations of drugs and crystalline side chain polymers to provide controlled and/or sustained release drug formulations.
    Type: Grant
    Filed: December 4, 2007
    Date of Patent: February 17, 2015
    Assignee: Landec, Inc.
    Inventors: David Taft, Steven Bitler, Qiang Zheng, Adam Bell, Stelios Tzannis
  • METHODS FOR ADMINISTERING SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS USING A DISPENSING DEVICE
    Publication number: 20150038898
    Abstract: Systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject using a device are disclosed. The dispensing device includes a lock-out feature and a means to retard or prevent saliva and/or moisture ingress such that the drug dosage forms in the device remain dry prior to administration.
    Type: Application
    Filed: June 16, 2014
    Publication date: February 5, 2015
    Inventors: Pamela Palmer, Andrew Poutiatine, Charles Rampersaud, Bruce Edwards, Edmond Chiu, Thomas Schreck, Stelios Tzannis, Lawrence Hamel, William Kolosi, Sascha Retailleau
  • Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
    Patent number: 8945592
    Abstract: Compositions and methods effective to minimize or eliminate the presence of oxidative degradation products in solid dosage forms comprising sufentanil are provided.
    Type: Grant
    Filed: November 21, 2008
    Date of Patent: February 3, 2015
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Shamim Pushpala, Larry Hamel, Stelios Tzannis, Evangeline Cruz